Originally developed in the 1950s as a malaria treatment, hydralazine showed antihypertensive ability and was soon repurposed.[A186841] Hydralazine is a hydrazine derivative vasodilator used alone or as adjunct therapy in the treatment of hypertension and only as adjunct therapy in the treatment of heart failure.[A186820,L8782,L8785] Hydralazine is no longer a first line therapy for these indications since the development of newer antihypertensive medications.[T691] Hydralazine hydrochloride was FDA approved on 15 January 1953.[L8779]
Synonyms
(1Z)-1(2H)-Phthalazinone hydrazone
Hydrallazine
Hydrazone 1(2H)-phthalazinone
6-Hydralazine
1-Hydrazinophthalazine
Phthalazin-1-ylhydrazine
Hydralazine
Hydralazinum
1-Phthalazinylhydrazine
Idralazina
(2H)-Phthalazinone hydrazone
Hydralazine hydrochloride
Hypophthalin
Hydralazin
Hydrazinophthalazine
Hidralazina
Brand Names
Isosorbide dinitrate and hydralazine hydrochloride
Hydralazine HCl
Apresoline Tablets, 50mg
Hydralazine Hydrochloride Injection, USP
Nu-hydral Tab 50 mg
Hydralazine HCl and Hydrochlorothiazide
Isosorbide Dinitrate and Hydralazine Hydrochloride
PMS-hydralazine
Ser-AP-ES Tab
Hydralazine-10 Tab 10mg
Apresoline Tablets, 25mg
Apresoline hydrochloride
Hydralazine Hydrochloride
Hydralazine Hydrochloride Injection
Jamp-hydralazine
hydrALAZINE Hydrochloride
Asn-hydralazine
Apresoline
Novo-hylazin Tab 25mg
Novo-hylazin Tab 50mg
Ser-Ap-Es
HydrALAZINE Hydrochloride
Apresoline Tablets, 10mg
Hydralazine
HydrALAZINE hydrochloride
Hydralazine-50 Tab
Mint-hydralazine
Nu-hydral Tab 25mg
Hydralazine Hydrocloride
BiDil
Hydralazine-25 Tab
Apo-hydralazine
Novo-hylazin Tab 10mg USP
Nu-hydral Tab 10mg
Indication
Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension.[L8782] A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.[L8785]
Categories
Antihypertensive Agents
Antihypertensive Agents Indicated for Hypertension
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682